Cargando…

A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19

The novel coronavirus 2019-nCoV (SARS-CoV-2) infection that emerged in China in December 2019 has rapidly spread to become a global pandemic. This article summarizes the potential benefits of erythropoietin (EPO) in alleviating SARS-CoV-2 pathogenesis which is now called COVID-19. As with other coro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahebnasagh, Adeleh, Mojtahedzadeh, Mojataba, Najmeddin, Farhad, Najafi, Atabak, Safdari, Mohammadreza, Rezai Ghaleno, Hassan, Habtemariam, Solomon, Berindan-Neagoe, Ioana, Nabavi, Seyed Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IMSS. Published by Elsevier Inc. 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418647/ https://www.ncbi.nlm.nih.gov/pubmed/32863034 http://dx.doi.org/10.1016/j.arcmed.2020.08.002

Ejemplares similares

Pharmacological treatments of COVID-19
por: Sahebnasagh, Adeleh, et al.
Publicado: (2020)

The prophylaxis and treatment potential of supplements for COVID-19
por: Sahebnasagh, Adeleh, et al.
Publicado: (2020)

Effect of heart rate control with amiodarone infusion on hemodynamic and clinical outcomes in septic shock patients with tachycardia: a prospective, single-arm clinical study
por: Khataminia, Masoud, et al.
Publicado: (2021)

Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
por: Dowran, Razieh, et al.
Publicado: (2020)

Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
por: Shahrami, Bita, et al.
Publicado: (2020)

Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
por: Habtemariam, Solomon, et al.
Publicado: (2020)

Correlation of biofilm formation, virulence factors, and phylogenetic groups among Escherichia coli strains causing urinary tract infection: A global systematic review and meta-analysis
por: Mirzahosseini, Hossein Karballaei, et al.
Publicado: (2023)

Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients
por: Sahebnasagh, Adeleh, et al.
Publicado: (2021)

Melatonin Supplementation May Improve the Outcome of Patients with Hemorrhagic Stroke in the Intensive Care Unit
por: Dianatkhah, Mehrnoush, et al.
Publicado: (2017)

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
por: Habtemariam, Solomon, et al.
Publicado: (2020)

The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients
por: Najafi, Atabak, et al.
Publicado: (2014)

Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
por: Habtemariam, Solomon, et al.
Publicado: (2020)

Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID‐19
por: Cismaru, Cosmin Andrei, et al.
Publicado: (2020)

Rationale for Effective Prophylaxis Against COVID‐19 Through Simultaneous Blockade of Both Endosomal and Non‐Endosomal SARS‐CoV‐2 Entry into Host Cell
por: Nabavi, Seyed Fazel, et al.
Publicado: (2021)

Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020)

Randomized Trial of the Effect of Magnesium Sulfate Continuous Infusion on IL-6 and CRP Serum Levels Following Abdominal Aortic Aneurysm Surgery
por: Mojtahedzadeh, Mojtaba, et al.
Publicado: (2016)

Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis
por: Shahrami, Bita, et al.
Publicado: (2020)

Rapidly Changing Tachyarrhythmia in Acute Stroke
por: Najafi, Atabak, et al.
Publicado: (2013)

Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020)

Evaluation of the Anti-Inflammatory Effects of Peri-Operative Infusion of Magnesium Sulfate on the Microsurgical Procedures for Intracranial Tumors
por: Etezadi, Farhad, et al.
Publicado: (2014)

COVID-19 and antimalarials. Have we been doing it wrong all along?
por: Cismaru, Cosmin Andrei, et al.
Publicado: (2021)

Effect of Famotidine on COVID-19: Killing Virus or Opposing ARDS?
por: Hosseini, Mahnaz Sadat, et al.
Publicado: (2023)

Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
por: Roostaei Firozabad, Amirreza, et al.
Publicado: (2021)

Effects of Donepezil and Medroxyprogesterone Versus Placebo on Weaning in Adult Patients With Non-Pulmonary Etiologies Receiving Invasive Mechanical Ventilation: A triple‐blind Randomized Clinical Trial
por: Alizadeh, Zahra, et al.
Publicado: (2021)

LipoxinA4 as a Potential Prognostic Marker of COVID-19
por: Jamali, Farzaneh, et al.
Publicado: (2022)

Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS
por: Amini, Shahideh, et al.
Publicado: (2022)

Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series?
por: Cismaru, Andrei Cosmin, et al.
Publicado: (2020)

A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases
por: Šudomová, Miroslava, et al.
Publicado: (2019)

Early goal-directed therapy reduces mortality in adult patients with severe sepsis and septic shock: Systematic review and meta-analysis
por: Chelkeba, Legese, et al.
Publicado: (2015)

Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
por: Simon, Timea, et al.
Publicado: (2015)

CRISPR/Cas9: A Potential Life-Saving Tool. What’s next?
por: Gulei, Diana, et al.
Publicado: (2017)

Combined Therapy in Cancer: The Non-coding Approach
por: Gulei, Diana, et al.
Publicado: (2018)

Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9
por: Gulei, Diana, et al.
Publicado: (2019)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

High-dose amikacin for achieving serum target levels in critically ill elderly patients
por: Sadeghi, Kourosh, et al.
Publicado: (2018)

Achievement of Vancomycin Therapeutic Goals in Critically Ill Patients: Early Individualization May Be Beneficial
por: Shahrami, Bita, et al.
Publicado: (2016)

Analgesic Efficacy of Nephrostomy Tract inFiltration of Bupivacaine and Ketamine after Tubeless Percutaneous Nephrolithotomy: A Prospective Randomized Trial
por: Shariat Moharari, Reza, et al.
Publicado: (2016)

The Role of Nrf2 Activity in Cancer Development and Progression
por: Zimta, Alina-Andreea, et al.
Publicado: (2019)

A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2
por: Devi, Kasi Pandima, et al.
Publicado: (2022)

Recombinant human erythropoietin reduces plasminogen activator inhibitor and ameliorates pro-inflammatory responses following trauma
por: Shiehmorteza, M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7o4su69f00pibrai1v3m8e4t22